AusMedtech 2016 will next week attract more than 300 medical technology developers and professionals to Adelaide - to advance one of Australia’s fastest growing and evolving sectors.
The ninth annual AusMedtech national conference, to advance Australia’s medtech sector (devices and diagnostics), will be officially opened by the Hon Kyam Maher MLC, Minister for Manufacturing and Innovation for the Government of South Australia and will feature a working lunch with the Hon Jack Snelling MP, Minister for Health, Minister for Mental Health and Substance Abuse, Minister for the Arts and Minister for Health Industries to discuss: Delivering medtech growth in South Australia.
Australia’s medtech sector has advanced vigorously in recent years, propelled by research developments and innovations in the biomedical sphere. Australia now has an established community of companies, estimated to be more than 1,000, - mostly start-up – operating within Australia’s medtech industry.
The two-day AusMedtech conference will highlight this fast-moving industry and feature many leading international and local speakers.
CEO and Director of Trajan Scientific and Medical Stephen Tomisich, drawing on his extensive leadership and partnership development experience, will discuss how sustainable scientific and medical device companies are built in Australia. Mr Tomisich has forged collaborations with industry, academic and government throughout his career, and as a consequence, has delivered lasting outcomes to both the scientific and wider community.
Additional topics AusMedtech will cover include supporting local developers achieve global success; advances in digital health; capital raising; government initiatives and Australian’s start-ups.
AusMedtech’s networking events and additional activities will complement these key themes:
This event has been organised with support from host partner BioSA and dinner partner Cook Medical and session and event partners and exhibitors. AusMedtech 2016 will be held in Adelaide 10 -11 May at the Adelaide Convention Centre.
Details of the event, including the full program are available at: http://www.ausmedtech.com.au
To request a media pass or for media enquiries:
Lorraine Chiroiu, AusBiotech’s Chief Industry Affairs Officer
P: +61 (0) 3 9828 1414
M: +61 (0) 429 801 118
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.